Medetomidine, a veterinary sedative, is now turning up in heroin, diazepam and fentanyl across the UK and US.
Articles on Opioid crisis
Displaying 1 - 20 of 97 articles
Conflicting claims about kratom are widespread, but scientific evidence makes the risks clear.
Supervised consumption sites have real shortcomings. But the government’s case for closing them relies on a narrow definition of success and abandons the people the sites were designed to reach.
For 50 years, St. Francis Inn in Philadelphia has served the poorest and most vulnerable people in Kensington.
Substance use disorders are widespread in the US, but many people wrongly equate detoxing with being cured.
Philly’s opioid addiction crisis is constantly evolving. Local health care workers and researchers explain some of the latest substances, side effects and treatments.
As with climate change, why are we so slow to recognise the existential threat that drug use poses to humanity?
Alberta’s controversial approach to the opioid crisis rejects harm reduction, including supervised consumption sites. Despite recent UCP claims that the program is working, more evidence is needed.
B.C. is facing a toxic drug crisis, however, forcing people into involuntary treatment will cause more harm than good.
Primary prevention is a crucial but underused component of a comprehensive public health approach to ending the opioid crisis — starting with children.
It happens in journalism and it happens in the arts. But in Congress – where just 2% of representatives held blue-collar or service-industry jobs before entering politics – it’s rampant.
The company helped spur a public health crisis through its deceptive marketing and aggressive sales of prescription opioids.
The toxic drug crisis is not only about fatalities. A much larger number of people survive overdoses, and are left with brain injuries. A national strategy to support and treat them is crucial.
Decriminalizing drugs is not intended as a solution to drug problems. Rather, it is a critical first step that’s necessary, but not sufficient, for replacing prohibition with a public health approach.
Calls to destigmatize language around drug addiction must be combined with action to change policies that stigmatize people in early recovery.
Undertreated pain can result in unnecessary suffering and a greater likelihood of long-term chronic pain.
Harm reduction is grounded in evidence. But policies, stigma and ignorance about substance use still create barriers in battling Canada’s drug poisoning crisis.
Higher levels of income inequality in youth are associated with increased ‘deaths of despair’ in young Canadians.
The Pulitzer Prize-winning author is just one of many artists from Appalachia who are probing the crisis in their work, while taking pains to ensure that it doesn’t define the region and its people.
Decriminalization helps recharacterize drug addiction as a chronic health condition instead of a criminal activity, reduces the stigma associated with drug use and improves treatment options.
Top contributors
-
Medical Director of Opioid Policy Research, Brandeis University
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Associate Professor of History, University at Buffalo
-
PhD Candidate, School of Population and Public Health, University of British Columbia
-
PhD Candidate, School of Nursing, University of British Columbia
-
Postdoctoral Fellow, Harvard University
-
Director of Translational Institute of Medicine (TIME), Queen's University, Ontario
-
Professor of Law, Indiana University
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Visiting Assistant Professor of Sociology, College of the Holy Cross
-
Professor, Department of Sociology and Anthropology, University of Guelph
-
Co-Director, Opioid Prescribing Engagement Network and Assistant Professor, University of Michigan
-
Director of the Master of Bioethics degree program at the Berman Institute of Bioethics, Johns Hopkins University
-
Vice-Dean, Faculty of Pain Medicine, ANZCA, Flinders University
-
Reader, Psychology and Language Sciences Division, UCL